Rocky Road To Glioma Approval: BNCT Firm Stella Redesigns Japan PII Trial

 
• By Lisa Takagi
  
BNCT for head and neck cancer
Stella's BNCT drug already approved for head and neck cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia